Please login to the form below

Not currently logged in


This page shows the latest budesonide news and features for those working in and with pharma, biotech and healthcare.

Phase 3 trial of AstraZeneca and Avillion’s PT027 shows promise for asthma patients

Phase 3 trial of AstraZeneca and Avillion’s PT027 shows promise for asthma patients

AstraZeneca (AZ) and Avillion have announced positive phase 3 trial results from the MANDALA study, showing that PT027 – albuterol/budesonide – demonstrated a statistically significant decrease in the risk of a severe ... In secondary endpoints,

Latest news

More from news
Approximately 3 fully matching, plus 65 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2016 Deal Watch October 2016

    410. AstraZeneca (UK). Cilag J&J (US). Asset acquisition. Rhinocort (budesonide) nasal spray for rhinitis, global rights excluding US.

  • Deal Watch November 2015 Deal Watch November 2015

    So selling off the US rights for Entocort (budesonide), in the non-strategic field of mild to moderate Crohn's disease seems like small beer but the $380m paid by Perrigo ... 386. AstraZeneca. Perrigo. Acquisition - asset. Entocort (budesonide) marketed

  • Pharma deals in August 2015 Pharma deals in August 2015

    Baxalta aside, it has been a busy year for Shire which in February acquired the company Meritage bringing in a phase III ready oral budesonide solution for eosinophilic oesophagitis [an orphan

  • Pharma deals in July 2015 Pharma deals in July 2015

    Secondly, AZ sold Entocort (budesonide) global rights except the US to Tillotts, for $215m representing a sales multiple of 4. ... 250+. AstraZeneca / Tillotts. Product acquisition. Entocort (budesonide) marketed. 215. Occuleve / Allergan.

  • Medius Deal Watch table for February 2015 Medius Deal Watch table for February 2015

    Collaboration - develop and commercialise. 265. Meritage Pharma/ Shire. Phase 3-ready oral budesonide suspension (OBS) - eosinophilic esophagitis (EoE).

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....